Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab

NCT06304545 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Camrelizumab
DRUG: Chemotherapy
RADIATION: Radiotherapy

Sponsor

Harbin Medical University